A SHR-1210 BE Study on Healthy Subjects

NCT05799183 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's R\&D Strategy adjusted

Conditions

Advanced Tumors

Interventions

DRUG: SHR-1210
DRUG: SHR-1210

Sponsor

Jiangsu HengRui Medicine Co., Ltd.